Bivacor appoints veteran medical device executive raymond w. cohen as chairman of the board of directors

Huntington beach, calif.--(business wire)--bivacor, inc., a clinical-stage medical technology company developing a total artificial heart (tah), today announced that raymond w. cohen has been appointed chairman of its board of directors. mr. cohen is an accredited public company director with over 40 years of experience in the life sciences industry. he currently serves as chief executive officer and member of the board of directors of axonics, inc. (nasdaq: axnx), an irvine, calif. based globa.
AXNX Ratings Summary
AXNX Quant Ranking